NPM1 and myeloid neoplasm: A wealth of different data [72, 73] suggests that NPM1 mutations act as a founder genetic lesion in this kind of leukemia and therefore AML with NPM1 mutation has been included as a new provisional entity in the WHO 2008 classification of myeloid neoplasms [74].